RU94046405A - Pth-compounds and pharmaceutical composition containing thereof, method of synthesis of required polypeptides, nucleotide sequence, expression bacterial vector, bacterial host cells and combined protein - Google Patents

Pth-compounds and pharmaceutical composition containing thereof, method of synthesis of required polypeptides, nucleotide sequence, expression bacterial vector, bacterial host cells and combined protein

Info

Publication number
RU94046405A
RU94046405A RU94046405/04A RU94046405A RU94046405A RU 94046405 A RU94046405 A RU 94046405A RU 94046405/04 A RU94046405/04 A RU 94046405/04A RU 94046405 A RU94046405 A RU 94046405A RU 94046405 A RU94046405 A RU 94046405A
Authority
RU
Russia
Prior art keywords
pth
synthesis
compounds
pharmaceutical composition
nucleotide sequence
Prior art date
Application number
RU94046405/04A
Other languages
Russian (ru)
Other versions
RU2130945C1 (en
Inventor
Вилфрид Бауэр
Ch]
Робин Брекенридж
Франсуа Кардино
Франк Гомберт
Германн Грам
Пол Рэмэдж
Гельмут Шнайдер
De]
Рудольф Ваэльхли
Райнер Альберт
Ян Люис
Original Assignee
Сандоз Лтд. (CH)
Сандоз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сандоз Лтд. (CH), Сандоз Лтд. filed Critical Сандоз Лтд. (CH)
Priority claimed from PCT/EP1993/001749 external-priority patent/WO1994002510A2/en
Publication of RU94046405A publication Critical patent/RU94046405A/en
Application granted granted Critical
Publication of RU2130945C1 publication Critical patent/RU2130945C1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

FIELD: molecular biology, biotechnology. SUBSTANCE: invention relates to variants of parathyroid hormone (PTH), method of their synthesis, pharmaceutical compositions containing indicated PTH-variants and their use as pharmaceutical agents. EFFECT: improved method of synthesis, enhanced effectiveness.

Claims (1)

Изобретение касается вариантов паратироидного гормона (ПТГ), способа их получения, фармацевтических составов, содержащих указанные варианты ПТГ, а также их использования в качестве фармацевтических агентов.The invention relates to variants of parathyroid hormone (PTH), a method for their preparation, pharmaceutical compositions containing these PTH variants, as well as their use as pharmaceutical agents.
RU94046405A 1993-04-19 1993-07-06 Pth-compounds, method of their synthesis, pharmaceutical composition containing their, dna fragment and fused protein RU2130945C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939308033A GB9308033D0 (en) 1993-04-19 1993-04-19 Organic compounds
GB9308033.1 1993-04-19
PCT/EP1993/001749 WO1994002510A2 (en) 1992-07-15 1993-07-06 Analogs of pth

Publications (2)

Publication Number Publication Date
RU94046405A true RU94046405A (en) 1996-10-27
RU2130945C1 RU2130945C1 (en) 1999-05-27

Family

ID=10734068

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94046405A RU2130945C1 (en) 1993-04-19 1993-07-06 Pth-compounds, method of their synthesis, pharmaceutical composition containing their, dna fragment and fused protein

Country Status (2)

Country Link
GB (1) GB9308033D0 (en)
RU (1) RU2130945C1 (en)

Also Published As

Publication number Publication date
GB9308033D0 (en) 1993-06-02
RU2130945C1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
RU94046367A (en) Dna, host cell, method of protein preparing, protein, pharmaceutical preparation, antibody, use of antibody
FR2730637B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING NUCLEIC ACIDS, AND USES THEREOF
RU95115239A (en) Erythropoietin analog
BR9610511B1 (en) DNA constructs useful in gene therapy comprising at least one nucleic sequence of interest and pharmaceutical composition.
RU95108217A (en) Defective recombinant adenovirus, cell strain, pharmaceutical composition
RU94045919A (en) Antibodies, cells, polypeptide, dna, vectors, method of polypeptide preparing, method of antibody preparing, pharmaceutical composition
NO20061455L (en) 2.6 dioxopiperidine and pharmaceutical preparations containing them
RU94045952A (en) Domain of protease inhibitor, dna, vector, cell, method of preparing protease inhibitor, pharmaceutical composition, use of domain
DE59410380D1 (en) ENDOSOMOLYTICALLY EFFECTIVE PARTICLES
MA23490A1 (en) LIPOPEPTIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, COMPOSITION IN CONTAINING THEM AND THEIR USE.
PT1079849E (en) USE OF HMG PROTEINS FOR THE PREPARATION OF MEDICINES WITH CYTOTOXIC ACTIVITY
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
RU94044534A (en) Thiazole amino derivatives, processes for preparation thereof and pharmaceutical compositions containing said derivatives
KR950700326A (en) Paratormon fragments, methods for their preparation and pharmaceuticals containing them (PARATHYROID HORMONE FRAGMENTS, THEIR PREPARATION AND MEDICAMENTS CONTAINING THE SAME)
BR0312889A (en) Pegged t20 polypeptide
ATE69727T1 (en) COMPOSITION FOR THE TREATMENT OF PATIENTS SUFFERING FROM HAEMOPHILIA-A INHIBITOR.
DK383388A (en) 3-DEMETHYL-4-FLUORO-MEVALONIC ACID DERIVATIVES, THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS THEREOF, THEIR USE AND INTERMEDIATES FOR THEIR PREPARATION
EP0990703A4 (en) Novel polypeptide, dna encoding the same and use thereof
RU94046405A (en) Pth-compounds and pharmaceutical composition containing thereof, method of synthesis of required polypeptides, nucleotide sequence, expression bacterial vector, bacterial host cells and combined protein
RU94046052A (en) Agglutination genes, yeast
DE50011068D1 (en) FRAGMENTS OF THE VIRUS PROTEIN 2 OR 3 OF THE POLYOMAVIRUS AS DRIVES FOR ACTIVE SUBSTANCES
AR013801A1 (en) NEW MOLECULES OF ISOLATED NUCLEIC ACID, A HYDROLASSE HYDROLASSE EPOXIDE PROTEIN OF ISOLATED HEMATOPHAGO ART, A FORMULATION OF PULGE HYDROLASSE DEEPOXIDE PROTEINS, A THERAPEUTIC COMPOSITION THAT REDUCES HOSPITAL INFRASTAGATION; USE OF SUCH COMPOSITION FOR
DE69315730D1 (en) Process for the preparation of peptides and new intermediates therefor
RU94019991A (en) Antibiotic composition
EA200000709A1 (en) BETA LIPOTROPIN AND ITS APPLICATIONS

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20100707